The publication asks: Will football be saved by a "long-haired, bespectacled nerd" developing MRI-based methods for free radical detection?
The New Yorker Profiles the Martinos Center's Reisa Sperling and Her work With Alzheimer's
In the June 24 issue of The New Yorker, Jerome Groopman looks at efforts to treat Alzheimer's Disease preemptively, before any symptoms appear. This year, the NIH committed $36 million to a trial overseen by the Martinos Center's Reisa Sperling and Paul Aisen of the University of California, San Diego, to explore the possibility of preventing the disease. Read a portion of the article on The New Yorker's website.